These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 6458882)
21. Comparative in vitro antibacterial activity of seven semi-synthetic penicillins against aerobic gram-negative bacteria and enterococci. Thabaut A; Durosoir JL; Saliou P Infection; 1982; 10 Suppl 3():S249-56. PubMed ID: 7152690 [TBL] [Abstract][Full Text] [Related]
22. A turbidimetric study of the responses of selected strains of Pseudomonas aeruginosa to eight antipseudomonal beta-lactam antibiotics. Greenwood D; Eley A J Infect Dis; 1982 Jan; 145(1):110-7. PubMed ID: 6459389 [TBL] [Abstract][Full Text] [Related]
23. [Comparative activity of azlocillin on Pseudomonas species excluding Pseudomonas aeruginosa]. Monteil H; Peladan F; Zinsius M Presse Med; 1984 Mar; 13(13):780-4. PubMed ID: 6324160 [TBL] [Abstract][Full Text] [Related]
24. Comparison of the in vitro activity of new beta-lactams and aminoglycosides against clinical isolates of Pseudomonas aeruginosa. Patzer J; Gieburowska R; Dzierzanowska D Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Oct; 253(1):110-20. PubMed ID: 6817544 [TBL] [Abstract][Full Text] [Related]
25. Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and aminoglycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa. Perea EJ; Nogales MC; Aznar J; Martin E; Iglesias MC J Antimicrob Chemother; 1980 Jul; 6(4):471-7. PubMed ID: 6253432 [No Abstract] [Full Text] [Related]
26. Comparative activity and beta-lactamase stability of carbenicillin, ticarcillin, azlocillin, mezlocillin and cefotaxime. Tselentis J; Cordossis T; Kosmidis J; Lambropoulos S; Melissinos K J Antimicrob Chemother; 1981 Oct; 8(4):317-21. PubMed ID: 6271725 [No Abstract] [Full Text] [Related]
27. [In vitro activity of mezlocillin, azlocillin and carbenicillin against bacteroidaceae with particular reference to bacteroides fragilis (author's transl)]. Werner H; Krassemann C; Ungerechts J; Schmitz HJ Infection; 1977; 5(1):17-21. PubMed ID: 585371 [TBL] [Abstract][Full Text] [Related]
28. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics. Gwynn MN; Rolinson GN Infection; 1980; 8(2):73-80. PubMed ID: 6771215 [TBL] [Abstract][Full Text] [Related]
29. Comparative in vitro activity of aztreonam, other beta-lactam antibiotics and aminoglycosides against Pseudomonas aeruginosa. Venditti M; Brandimarte C; Santini C; Valente B; Martino P; Serra P Chemioterapia; 1984 Aug; 3(4):258-61. PubMed ID: 6442625 [TBL] [Abstract][Full Text] [Related]
30. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. Pickering LK; Rutherford I J Pharmacol Exp Ther; 1981 May; 217(2):345-9. PubMed ID: 6453219 [TBL] [Abstract][Full Text] [Related]
32. [In vitro comparative activity of 4 beta-lactams against Pseudomonas aeruginosa. Role of cefoperazone]. Joly-Guillou ML; Bergogne-Berezin E; Verin-Prevost C Pathol Biol (Paris); 1984 May; 32(5):408-11. PubMed ID: 6429612 [TBL] [Abstract][Full Text] [Related]
33. Comparative in vitro activity of ticarcillin, piperacillin, azlocillin and mezlocillin. Chattopadhyay B; Hall I; Curnow SR Curr Med Res Opin; 1983; 8(8):577-81. PubMed ID: 6653135 [TBL] [Abstract][Full Text] [Related]
34. Azlocillin and mezlocillin: new ureido penicillins. Fu KP; Neu HC Antimicrob Agents Chemother; 1978 Jun; 13(6):930-8. PubMed ID: 677860 [TBL] [Abstract][Full Text] [Related]
35. Comparative in vitro activity of azlocillin, ampicillin, mezlocillin, piperacillin, and ticarcillin, alone and in combination with an aminoglycoside. White GW; Malow JB; Zimelis VM; Pahlavanzadeh H; Panwalker AP; Jackson GG Antimicrob Agents Chemother; 1979 Apr; 15(4):540-3. PubMed ID: 111616 [TBL] [Abstract][Full Text] [Related]
36. Studies on the antibacterial activity of two new acylureidopenicillins, mezlocillin and azlocillin. Soares LA; Trabulsi LR Arzneimittelforschung; 1979; 29(12a):1932-4. PubMed ID: 543893 [TBL] [Abstract][Full Text] [Related]
37. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. Gavan TL; Jones RN; Barry AL; Fuchs PC; Gerlach EH; Matsen JM; Reller LB; Thornsberry C; Thrupp LD J Clin Microbiol; 1981 Jul; 14(1):67-72. PubMed ID: 6455443 [TBL] [Abstract][Full Text] [Related]
38. [Pseudomonas aeruginosa: acquired in vitro resistance to beta-lactams]. Thabaut A; Meyran M Pathol Biol (Paris); 1983 May; 31(5):387-91. PubMed ID: 6413939 [TBL] [Abstract][Full Text] [Related]
39. In vitro evaluation of new penicillins and cephalosporins upon P. aeruginosa and their interaction with mecillinam. Perea EJ; Palomares JC; GarcĂa-Iglesias MC Chemotherapy; 1980; 26(4):282-8. PubMed ID: 6248300 [TBL] [Abstract][Full Text] [Related]
40. In vitro activity of mezlocillin and azlocillin compared with that of four other penicillins and two aminoglycosides. Barry AL; Thornsberry C; Jones RN; Gavan TL Cleve Clin Q; 1980; 47(4):311-9. PubMed ID: 6451334 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]